Supernus Pharmaceuticals Series A

Supernus Pharmaceuticals is an award-winning biopharmaceutical company with over 30 years of experience in developing and commercializing products to treat central nervous system (CNS) diseases. They offer novel products designed to provide important health benefits to patients living with CNS diseases and are actively engaged in research and development of promising product candidates.